Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Comparative Dose-Response of Intrathecal Dexmedetomidine for Post-Spinal Shivering [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study comparing different dose levels of intrathecal dexmedetomidine for postoperative shivering following spinal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Al-Azhar University | Conditions: Post-Spinal Shivering | Phase 3 | Status: NOT_YET_RECRUITING